
|Videos|October 27, 2011
Dr. Scagliotti Gives 3 Important Lung Cancer Takeaway Points
Author(s)Giorgio V. Scagliotti, MD, PhD
Dr. Giorgio Scagliotti from the University of Turin Gives 3 Important Lung Cancer Takeaway Points
Advertisement
Giorgio V. Scagliotti, MD, PhD, head of the Thoracic Oncology Unit, Department of Clinical and Biological Sciences, University of Turin, San Luigi Hospital, Orbassano, Italy, explains 3 lung cancer topics that require more awareness and research to produce optimal results in the future.
- Regardless of the cost a connection between early lung cancer detection and lower mortality needs to be established.
- To ensure the best treatment and diagnosis physicians need to refer every new patient with lung cancer to a multidisciplinary clinic.
- Further genomic investigation is needed and can increase survival in at least 30% of patients.
Advertisement
Advertisement
Advertisement
Trending on OncLive
1
HERIZON-GEA-01 PD-L1 Subgroup Data Support Zanidatamab Combo as a New Frontline SOC in HER2+ GEA
2
Antibody-Drug Conjugates in Lung Cancer: The Tip of the Iceberg
3
Selinexor Plus Ruxolitinib Yields Superior Spleen Responses, OS Signal in JAK Inhibitor–Naïve Myelofibrosis
4
Retrospective Data Show Zanubrutinib May Less AFib Burden in Real-World CLL
5






























































